U.S. market Closed. Opens in 1 hour 3 minutes

RNXT | RenovoRx, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of RevenueN/A6.00K9.00KN/AN/A
Gross ProfitN/A-6.00K-9.00KN/AN/A
Operating Expenses11.40M9.95M5.67M3.20M3.90M
Selling, General & Admin5.73M5.65M2.63M818.00K899.00K
Research & Development5.67M4.30M3.04M2.39M3.00M
Other Operating ExpensesN/A61.00K119.00K-7.00K2.00K
Operating Income-11.40M-9.95M-5.67M-3.20M-3.90M
Other Expenses / Income1.16M61.00K-653.00K-594.00K57.00K
Before Tax Income-10.23M-9.89M-6.32M-3.80M-3.84M
Income Tax Expenses-6.00-118.00K772.00K587.00K-63.00K
Net Income-10.23M-9.77M-7.10M-4.38M-3.78M
Interest Expenses108.00K57.00K-834.00K590.00KN/A
Basic Shares Outstanding10.29M9.05M8.93M8.66M8.66M
Diluted Shares Outstanding10.29M9.05M8.93M8.66M8.66M
EBITDA-11.39M-9.95M-5.72M-3.21M-3.83M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-10.12M-9.83M-7.16M-3.21M-3.84M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙